Calgary, Canada

David James Press

This inventor holds 9 USPTO granted patents and 7 published patent applications. Top assignee: Enveric Biosciences Canada Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David James Press. Retrieved from https://idiyas.com/inventor/david-james-press

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David James Press

Introduction

David James Press is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of pharmaceuticals and recreational drugs through his innovative patents. With a total of seven patents to his name, Press continues to push the boundaries of scientific research and development.

Latest Patents

Among his latest patents are the "Fused heterocyclic mescaline derivatives," which disclose novel fused heterocyclic mescaline derivative compounds. These compounds include pharmaceutical and recreational drug formulations, along with methods for making and using them. Another significant patent is for "Substituted n-propylamine fused heterocyclic mescaline derivatives," which also presents novel fused mescaline derivative compounds. This patent includes substituted N-propylamine fused dioxolane mescaline derivatives and their respective formulations, along with methods for their production and application.

Career Highlights

David James Press has established himself as a key figure in the field of drug formulation and development. His work at Enveric Biosciences Canada Inc. has allowed him to collaborate with other talented professionals in the industry. His innovative approach to drug development has garnered attention and respect from his peers.

Collaborations

Press has worked alongside notable colleagues such as Kaveh Matinkhoo and Glynnis Elizabeth Jensen. These collaborations have further enhanced his research and development efforts, leading to groundbreaking advancements in his field.

Conclusion

David James Press exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of drug formulation and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…